1. Home
  2. TROX vs SUPN Comparison

TROX vs SUPN Comparison

Compare TROX & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROX
  • SUPN
  • Stock Information
  • Founded
  • TROX N/A
  • SUPN 2005
  • Country
  • TROX United States
  • SUPN United States
  • Employees
  • TROX N/A
  • SUPN N/A
  • Industry
  • TROX Major Chemicals
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TROX Industrials
  • SUPN Health Care
  • Exchange
  • TROX Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • TROX 1.7B
  • SUPN 1.9B
  • IPO Year
  • TROX 2005
  • SUPN 2012
  • Fundamental
  • Price
  • TROX $11.00
  • SUPN $35.57
  • Analyst Decision
  • TROX Strong Buy
  • SUPN Hold
  • Analyst Count
  • TROX 5
  • SUPN 1
  • Target Price
  • TROX $18.00
  • SUPN $36.00
  • AVG Volume (30 Days)
  • TROX 1.2M
  • SUPN 422.4K
  • Earning Date
  • TROX 10-24-2024
  • SUPN 11-04-2024
  • Dividend Yield
  • TROX 4.53%
  • SUPN N/A
  • EPS Growth
  • TROX N/A
  • SUPN 130.79
  • EPS
  • TROX 0.27
  • SUPN 1.07
  • Revenue
  • TROX $3,084,000,000.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • TROX $11.09
  • SUPN $7.82
  • Revenue Next Year
  • TROX $3.44
  • SUPN N/A
  • P/E Ratio
  • TROX $41.53
  • SUPN $33.25
  • Revenue Growth
  • TROX 9.63
  • SUPN 6.79
  • 52 Week Low
  • TROX $10.69
  • SUPN $25.53
  • 52 Week High
  • TROX $20.70
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • TROX 30.75
  • SUPN 53.46
  • Support Level
  • TROX $10.69
  • SUPN $35.87
  • Resistance Level
  • TROX $13.14
  • SUPN $39.37
  • Average True Range (ATR)
  • TROX 0.39
  • SUPN 1.69
  • MACD
  • TROX -0.13
  • SUPN 0.03
  • Stochastic Oscillator
  • TROX 13.06
  • SUPN 36.03

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. North America, Asia-Pacific and Europe the Middle East, and Africa regions contribute the vast majority of revenue.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: